-Business Standard Centre owes states Rs 5,595 crore for work already completed A day after the government claimed success in Parliament over implementing the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS), government data reveal the Centre owes states Rs 5,595 crore dues for work already completed — 16 per cent of the budgeted funds for the scheme — causing stress to people, particularly in drought-hit states. After two quarters of revival in...

-The Telegraph New Delhi: One in five patients in India treated for heart attacks had to pay over a third of their annual household income from their pockets despite health insurance, according to a study that doctors say highlights poor health care protection. The study probing the financial impacts of serious acute coronary events in a sample of 1,635 patients from 41 hospitals across the country has also found that 60 per...

-Frontline Former psephologist Yogendra Yadav, now a member of the political collective Swaraj Abhiyan, recently toured India’s drought-affected districts. He called it a Samvedna Yatra. During the tour, he took note of the agony in rural areas affected by what he calls “one of the worst droughts in independent India” The drought, according to him, has left farmers and the larger rural community in extreme distress, leading to damaging changes in...

-The Hindu Business Line It has worked as a rural safety net. But the Centre has other budgetary priorities A decade after the Mahatma Gandhi National Rural Employment Guarantee Scheme came into force, the NDA government has come around to accepting its usefulness — and that, in a difficult agriculture year. Last February, the Prime Minister disparaged the programme for merely digging pits. But only a few days ago, the finance minister...

-The Hindu Haemophilia patients dependent on U.S. drug likely to be worst-hit. In a move that could inflate the cost of essential life-saving imported drugs, the Finance Ministry has withdrawn exemption of 76 medicines from customs duties. The list includes 10 HIV drugs and at least four cancer drugs, but haemophilia patients are likely to be the most affected by the decision. Haemophilia is a genetic disorder in which the patient tends to...